An Open-label Extension Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy
Clinical trial NCT02625090 · TERMINATED
Trial details
- NCT number
- NCT02625090
- Sponsor
- UCB Biopharma SRL
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-03
- Primary completion
- 2020-11-24
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.